Publications search

Found 37769 matches. Displaying 2491-2500
Yamazaki Y, Urrutia R, Franco LM, Giliani S, Zhang KJ, Alazami AM, Dobbs AK, Masneri S, Joshi A, Otaizo-Carrasquero F, Myers TG, Ganesan S, Bondioni MP, Ho ML, Marks C, Alajlan H, Mohammed RW, Zou FG, Valencia CA, Filipovich AH, Facchetti F, Boisson B, Azzari C, Al-Saud BK, Al-Mousa H, Casanova JL, Abraham RS, Notarangelo LD
Show All Authors

PAX1 is essential for development and function of the human thymus

SCIENCE IMMUNOLOGY 2020 FEB; 5(44):? Article eaax1036
We investigated the molecular and cellular basis of severe combined immunodeficiency (SCID) in six patients with otofaciocervical syndrome type 2 who failed to attain T cell reconstitution after allogeneic hematopoietic stem cell transplantation, despite successful engraftment in three of them. We identified rare biallelic PAX1 rare variants in all patients. We demonstrated that these mutant PAX1 proteins have an altered conformation and flexibility of the paired box domain and reduced transcriptional activity. We generated patient-derived induced pluripotent stem cells and differentiated them into thymic epithelial progenitor cells and found that they have an altered transcriptional profile, including for genes involved in the development of the thymus and other tissues derived from pharyngeal pouches. These results identify biallelic, loss-of-function PAX1 mutations as the cause of a syndromic form of SCID due to altered thymus development.
Toure A, Ghione P, Phillips S, Klute K, Leonard JP, Martin P
Show All Authors

Lymphoma Study Titles on ClinicalTrials.gov Lack Details Necessary for Study Identification

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2020 FEB; 20(2):E82-E86
ClinicalTrials.gov is used by clinicians and patients to identify clinical trials; however, finding a relevant trial can be challenging. We evaluated the ease with which key information about a trial for patients with lymphoma could be derived from the title. We performed 2 searches for lymphoma trials on ClinicalTrials.gov, 1 before and 1 after a major overhaul of the website in 2017. Despite the overhaul, the study titles continued to lack the information needed to understand and select an appropriate clinical trial. Background: ClinicalTrials.gov is used by clinicians and patients to identify clinical trials. We assessed the ease with which users could identify relevant trials related to lymphoma using the short and official titles. We hypothesized that lymphoma titles frequently lack important information. Materials and Methods: We performed 2 searches on ClinicalTrials.gov. The first search was performed before June 2017, when ClinicalTrials.gov underwent updates to improve usability. The second was performed after 2017. We assessed whether the short and official titles of each trial provided information on the study phase, eligible disease status, lymphoma histologic subtype, study intervention, primary objective, and the presence of randomization and placebo control. Results: Of the pre-overhaul lymphoma trials, the official versus short titles included information regarding study intervention (99% vs. 96%), study phase (82% vs. 14%), lymphoma histologic subtype (78% vs. 72%), disease status (46% vs. 35%), randomization (13% vs. 2%), presence of placebo (6% vs. 2%), and primary objective (38% vs. 26%). Of the post-overhaul trials, the official versus short titles included information regarding study intervention (97% vs. 96%), lymphoma histologic subtype (83% vs. 78%), study phase (78% vs. 8%), disease status (64% vs. 50%), primary objective (38% vs. 23%), presence of placebo (11% vs. 0%), and randomization (18% vs. 0%). Conclusion: The official titles were more informative than were the short titles on ClinicalTrials.gov. However, the short and official titles both often lacked the basic information needed to understand a clinical trial. This has persisted despite updates to the platform. These results highlight the need for standardization of the format and content included in study titles. (C) 2019 Elsevier Inc. All rights reserved.
Sparks S, Hayama R, Rout MP, Cowburn D
Show All Authors

Analysis of Multivalent IDP Interactions: Stoichiometry, Affinity, and Local Concentration Effect Measurements

INTRINSICALLY DISORDERED PROTEINS: Methods and Protocols 2020; 2141(?):463-475
Nuclear magnetic resonance (NMR) titration and isothermal titration calorimetry can be combined to provide an assessment of how multivalent intrinsically disordered protein (IDP) interactions can involve enthalpy-entropy balance. Here, we describe the underlying technical details and additional methods, such as dynamic light scattering analysis, needed to assess these reactions. We apply this to a central interaction involving the disordered regions of phe-gly nucleoporins (FG-Nups) that contain multiple phenylalanine-glycine repeats which are of particular interest, as their interactions with nuclear transport factors (NTRs) underlie the paradoxically rapid yet also highly selective transport of macromolecules mediated by the nuclear pore complex (NPC). These analyses revealed that a combination of low per-FG motif affinity and the enthalpy-entropy balance prevents high-avidity interaction between FG-Nups and NTRs while the large number of FG motifs promotes frequent FG-NTR contacts, resulting in enhanced selectivity.
Ghosh S, Sheppard LW, Holder MT, Loecke TD, Reid PC, Bever JD, Reuman DC
Show All Authors

Copulas and their potential for ecology

TROPICAL ECOSYSTEMS IN THE 21ST CENTURY 2020; 62(?):409-468
All branches of ecology study relationships among and between environmental and biological variables. However, standard approaches to studying such relationships, based on correlation and regression, provide only some of the complex information contained in the relationships. Other statistical approaches exist that provide a complete description of relationships between variables, based on the concept of the copula; they are applied in finance, neuroscience and elsewhere, but rarely in ecology. We explore the concepts that underpin copulas and the potential for those concepts to improve our understanding of ecology. We find that informative copula structure in dependencies between variables is common across all the environmental, species-trait, phenological, population, community, and ecosystem functioning datasets we considered. Many datasets exhibited asymmetric tail associations, whereby two variables were more strongly related in their left compared to right tails, or vice versa. We describe mechanisms by which observed copula structure and tail associations can arise in ecological data, including a Moran-like effect whereby dependence structures are inherited from environmental variables; and asymmetric or nonlinear influences of environments on ecological variables, such as under Liebig's law of the minimum. We also describe consequences of copula structure for ecological phenomena, including impacts on extinction risk, Taylor's law, and the temporal stability of ecosystem services. By documenting the importance of a complete description of dependence between variables, advancing conceptual frameworks, and demonstrating a powerful approach, we encourage widespread use of copulas in ecology, which we believe can benefit the discipline.
Tippett MK, Cohen JE
Show All Authors

Seasonality of Taylor's law of fluctuation scaling in all-India daily rainfall

NPJ CLIMATE AND ATMOSPHERIC SCIENCE 2020 JAN 17; 3(1):? Article UNSP 3
Here we show that the variance over time of all-India daily rainfall (AIR) can be related to the mean over time of AIR by a seasonally varying power law. Outside of the peak monsoon months of July and August, AIR variance increases in proportion to a positive power of mean daily rainfall. During July and August, monthly averages of AIR show little association with the corresponding variances. This power-law relationship of temporal variance to temporal mean is known in biological sciences as Taylor's law (TL) and in physical sciences as fluctuation scaling. We explain the seasonal variation in TL qualitatively by independent and identically distributed random sampling. Accounting for day-to-day correlation in AIR is sufficient to match quantitatively the observed power-law behavior. Our findings provide a quantitative month-specific assessment of the variability of AIR that could prove useful for the design of crop insurance and social safety nets for the large fraction of the population of the Indian subcontinent that depends on rainfed agriculture.
Brand P, Hinojosa-Diaz IA, Ayala R, Daigle M, Obiols CLY, Eltz T, Ramirez SR
Show All Authors

The evolution of sexual signaling is linked to odorant receptor tuning in perfume-collecting orchid bees

NATURE COMMUNICATIONS 2020 JAN 13; 11(1):? Article 244
Sexual signaling is an important reproductive barrier known to evolve early during the formation of new species, but the genetic mechanisms that facilitate the divergence of sexual signals remain elusive. Here we isolate a gene linked to the rapid evolution of a signaling trait in a pair of nascent neotropical orchid bee lineages, Euglossa dilemma and E. viridissima. Male orchid bees acquire chemical compounds from their environment to concoct species-specific perfumes to later expose during courtship. We find that the two lineages acquire chemically distinct perfumes and are reproductively isolated despite low levels of genome-wide differentiation. Remarkably, variation in perfume chemistry coincides with rapid divergence in few odorant receptor (OR) genes. Using functional assays, we demonstrate that the derived variant of Or41 in E. dilemma is specific towards its species-specific major perfume compound, whereas the ancestral variant in E. viridissima is broadly tuned to multiple odorants. Our results show that OR evolution likely played a role in the divergence of sexual communication in natural populations.
Dubin C, Del Duca E, Guttman-Yassky E
Show All Authors

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges

THERAPEUTICS AND CLINICAL RISK MANAGEMENT 2020; 16(?):1319-1332
Chronic hand eczema (CHE) is a common and burdensome inflammatory skin condition seen in up to 10% of the population, more often in high-risk occupational workers. Topical therapeutics comprise the standard of care, but up to 65% of cases do not resolve after treatment, and moderate-to-severe cases are often resistant to topical therapeutics and require systemic options instead. To date, there are no systemic therapeutics approved to treat CHE in the United States, but several drugs are under investigation as potential treatments for CHE. The primary focus of this review is on the novel therapeutics, topical and systemic, that are under investigation in recently completed or currently ongoing trials. This review also briefly outlines the existing treatments utilized for CHE, often with limited success or extensive adverse effects. CHE represents a major challenge for physicians and patients alike, and efforts to improve the minimally invasive diagnostic tools and treatment paradigms are ongoing. In the near future, CHE patients may benefit from new topical and systemic therapeutics that specifically target abnormally expressed immune markers.
Shaver RL, Jemec GBE, Freese R, Alavi A, Lowes MA, Goldfarb N
Show All Authors

A survey of clinicians regarding preferred severity assessment tools for hidradenitis suppurativa

INTERNATIONAL JOURNAL OF DERMATOLOGY 2020; ?(?):?
Wey B, Heavner ME, Wittmeyer KT, Briese T, Hopper KR, Govind S
Show All Authors

Immune Suppressive Extracellular Vesicle Proteins of Leptopilina heterotoma Are Encoded in the Wasp Genome

G3-GENES GENOMES GENETICS 2020 JAN; 10(1):1-12
Leptopilina heterotoma are obligate parasitoid wasps that develop in the body of their Drosophila hosts. During oviposition, female wasps introduce venom into the larval hosts' body cavity. The venom contains discrete, 300 nm-wide, mixed-strategy extracellular vesicles (MSEVs), until recently referred to as virus-like particles. While the crucial immune suppressive functions of L. heterotoma MSEVs have remained undisputed, their biotic nature and origin still remain controversial. In recent proteomics analyses of L. heterotoma MSEVs, we identified 161 proteins in three classes: conserved eukaryotic proteins, infection and immunity related proteins, and proteins without clear annotation. Here we report 246 additional proteins from the L. heterotoma MSEV proteome. An enrichment analysis of the entire proteome supports vesicular nature of these structures. Sequences for more than 90% of these proteins are present in the whole-body transcriptome. Sequencing and de novo assembly of the 460 Mb-sized L. heterotoma genome revealed 90% of MSEV proteins have coding regions within the genomic scaffolds. Altogether, these results explain the stable association of MSEVs with their wasps, and like other wasp structures, their vertical inheritance. While our results do not rule out a viral origin of MSEVs, they suggest that a similar strategy for co-opting cellular machinery for immune suppression may be shared by other wasps to gain advantage over their hosts. These results are relevant to our understanding of the evolution of figitid and related wasp species.
Burla R, La Torre M, Maccaroni K, Verni F, Giunta S, Saggio I
Show All Authors

Interplay of the nuclear envelope with chromatin in physiology and pathology

NUCLEUS 2020 JAN 1; 11(1):205-218
The nuclear envelope compartmentalizes chromatin in eukaryotic cells. The main nuclear envelope components are lamins that associate with a panoply of factors, including the LEM domain proteins. The nuclear envelope of mammalian cells opens up during cell division. It is reassembled and associated with chromatin at the end of mitosis when telomeres tether to the nuclear periphery. Lamins, LEM domain proteins, and DNA binding factors, as BAF, contribute to the reorganization of chromatin. In this context, an emerging role is that of the ESCRT complex, a machinery operating in multiple membrane assembly pathways, including nuclear envelope reformation. Research in this area is unraveling how, mechanistically, ESCRTs link to nuclear envelope associated factors as LEM domain proteins. Importantly, ESCRTs work also during interphase for repairing nuclear envelope ruptures. Altogether the advances in this field are giving new clues for the interpretation of diseases implicating nuclear envelope fragility, as laminopathies and cancer.